{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T16:02:12Z","timestamp":1781107332475,"version":"3.54.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","trasci.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Transfusion and Apheresis Science"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.transci.2026.104422","type":"journal-article","created":{"date-parts":[[2026,3,8]],"date-time":"2026-03-08T20:51:58Z","timestamp":1773003118000},"page":"104422","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thromboembolic complications and risk factors after fresh frozen plasma and prothrombin complex concentrate transfusion for anticoagulation reversal"],"prefix":"10.1016","volume":"65","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6723-8564","authenticated-orcid":false,"given":"\u0130smail","family":"Ata\u015f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d6zlem","family":"Bilira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00fcmin Murat","family":"Yaz\u0131c\u0131","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6khan","family":"Ersunan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hayri","family":"Canbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.transci.2026.104422_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1177\/0018578720946754","article-title":"Thromboembolic complications after receipt of prothrombin complex concentrate","volume":"56","author":"Owen","year":"2021","journal-title":"Hosp Pharm"},{"key":"10.1016\/j.transci.2026.104422_bib2","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1097\/EJA.0000000000001968","article-title":"Clinical guideline on reversal of direct oral anticoagulants in patients with life-threatening bleeding","volume":"41","author":"Grottke","year":"2024","journal-title":"Eur J Anaesthesiol"},{"key":"10.1016\/j.transci.2026.104422_bib3","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1177\/1076029616675970","article-title":"Reversal of anticoagulation and management of bleeding in patients on anticoagulants","volume":"23","author":"Dhakal","year":"2017","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/j.transci.2026.104422_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.tcm.2019.03.004","article-title":"A review of oral anticoagulants, old and new, in major bleeding and the need for urgent surgery","volume":"30","author":"Milling","year":"2020","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/j.transci.2026.104422_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.transci.2023.103759","article-title":"Use of four-factor prothrombin complex concentrate (4F-PCC) for management of bleeding not associated with therapeutic anticoagulant use","volume":"62","author":"Uttaro","year":"2023","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2026.104422_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.transci.2012.03.021","article-title":"J. Prothrombin complex concentrate for the urgent reversal of warfarin: assessment of a standard dosing protocol","volume":"46","author":"Wozniak","year":"2012","journal-title":"Transfus Apher Sci"},{"key":"10.1016\/j.transci.2026.104422_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1007\/s11239-022-02739-w","article-title":"Urgent procedures or surgeries in patients receiving oral anticoagulants: a systematic literature review","volume":"55","author":"Siegal","year":"2023","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.transci.2026.104422_bib8","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1161\/CIRCULATIONAHA.120.045769","article-title":"Factor Xa inhibitor-related intracranial hemorrhage: results from a multicenter, observational cohort receiving prothrombin complex concentrates","volume":"141","author":"Panos","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2026.104422_bib9","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1002\/ajh.21046","article-title":"Role of prothrombin complex concentrates in reversing warfarin anticoagulation: a review of the literature","volume":"83","author":"Leissinger","year":"2008","journal-title":"Am J Hematol"},{"key":"10.1016\/j.transci.2026.104422_bib10","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1161\/CIRCULATIONAHA.113.002283","article-title":"Efficacy and safety of a 4-factor prothrombin complex concentrate in patients on vitamin K antagonists presenting with major bleeding: a randomized, plasma-controlled, phase IIIb study","volume":"128","author":"Sarode","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/j.transci.2026.104422_bib11","unstructured":"Turkish Medicines and Medical Devices Agency (T\u0130TCK), KUB-COFACT 500 IU\/20 ml. \u3008https:\/\/www.ilacprospektusu.com\/ilac\/195\/cofact-20-ml-iv-enjektor-icin-coz-iceren-flakon\u3009, 2019 (accessed 12 December 2025)."},{"key":"10.1016\/j.transci.2026.104422_bib12","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.annemergmed.2015.04.036","article-title":"Thromboembolic events after vitamin K antagonist reversal with 4-factor prothrombin complex concentrate: exploratory analyses of two randomized, plasma-controlled studies","volume":"67","author":"Milling","year":"2016","journal-title":"Ann Emerg Med"},{"key":"10.1016\/j.transci.2026.104422_bib13","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S1474-4422(16)00110-1","article-title":"Fresh frozen plasma versus prothrombin complex concentrate in patients with intracranial hemorrhage related to vitamin K antagonists (INCH): a randomized trial","volume":"15","author":"Steiner","year":"2016","journal-title":"Lancet Neurol"},{"key":"10.1016\/j.transci.2026.104422_bib14","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1093\/neuros\/nyx327","article-title":"A retrospective propensity score-matched early thromboembolic event analysis of prothrombin complex concentrate vs fresh frozen plasma for warfarin reversal prior to emergency neurosurgical procedures","volume":"82","author":"Agarwal","year":"2018","journal-title":"Neurosurgery"},{"key":"10.1016\/j.transci.2026.104422_bib15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.3324\/haematol.10516","article-title":"The risk of recurrent venous thromboembolism after discontinuing anticoagulation in patients with acute proximal deep vein thrombosis or pulmonary embolism","volume":"92","author":"Prandoni","year":"2007","journal-title":"Haematologica"},{"key":"10.1016\/j.transci.2026.104422_bib16","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s13049-025-01334-1","article-title":"Prothrombin complex concentrate for reversal of oral anticoagulants in patients with oral anticoagulation-related critical bleeding: a systematic review of randomised clinical trials","volume":"33","author":"Ovesen","year":"2025","journal-title":"Scand J Trauma Resusc Emerg Med"},{"key":"10.1016\/j.transci.2026.104422_bib17","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1007\/s11239-022-02695-5","article-title":"Thromboembolism after treatment with 4-factor prothrombin complex concentrate or plasma for warfarin-related bleeding","volume":"54","author":"Go","year":"2022","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.transci.2026.104422_bib18","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1182\/bloodadvances.2022009015","article-title":"INR and vitamin K-dependent factor levels after vitamin K antagonist reversal with 4F-PCC or plasma","volume":"7","author":"Hood","year":"2023","journal-title":"Blood Adv"},{"key":"10.1016\/j.transci.2026.104422_bib19","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1007\/s40265-019-01179-w","article-title":"Prothrombin complex concentrates are superior to fresh frozen plasma for emergency reversal of vitamin K antagonists: a meta-analysis in 2606 subjects","volume":"79","author":"Hill","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/j.transci.2026.104422_bib20","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s11239-009-0412-5","article-title":"Warfarin anticoagulation reversal: management of the asymptomatic and bleeding patient","volume":"29","author":"Makris","year":"2010","journal-title":"J Thromb Thrombolysis"},{"key":"10.1016\/j.transci.2026.104422_bib21","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1345\/aph.1Q096","article-title":"Prothrombin complex concentrate for critical bleeding","volume":"45","author":"Patanwala","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/j.transci.2026.104422_bib22","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1159\/000321766","article-title":"Effect of prothrombin complex concentrate on hematoma enlargement and clinical outcome in patients with anticoagulant-associated intracerebral hemorrhage","volume":"31","author":"Kuwashiro","year":"2011","journal-title":"Cereb Dis"}],"container-title":["Transfusion and Apheresis Science"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1473050226000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T15:35:58Z","timestamp":1781105758000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1473050226000546"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":22,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S1473050226000546"],"URL":"https:\/\/doi.org\/10.1016\/j.transci.2026.104422","relation":{},"ISSN":["1473-0502"],"issn-type":[{"value":"1473-0502","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thromboembolic complications and risk factors after fresh frozen plasma and prothrombin complex concentrate transfusion for anticoagulation reversal","name":"articletitle","label":"Article Title"},{"value":"Transfusion and Apheresis Science","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.transci.2026.104422","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"104422"}}